These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18385987)

  • 1. Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin.
    Brouwers EE; Tibben MM; Pluim D; Rosing H; Boot H; Cats A; Schellens JH; Beijnen JH
    Anal Bioanal Chem; 2008 May; 391(2):577-85. PubMed ID: 18385987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
    Yamada K; Kato N; Takagi A; Koi M; Hemmi H
    Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study of the use of saliva as an alternative to leukocytes as a source of DNA for the study of Pt-DNA adducts in cancer patients receiving platinum-based chemotherapy.
    Taylor SE; Wood JP; Thomas AL; Jones GD; Reid HJ; Sharp BL
    Anal Bioanal Chem; 2014 Dec; 406(30):8033-6. PubMed ID: 25374124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry.
    Björn E; Nygren Y; Nguyen TT; Ericson C; Nöjd M; Naredi P
    Anal Biochem; 2007 Apr; 363(1):135-42. PubMed ID: 17286953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of platinum in rat dorsal root ganglion using ICP-MS.
    Ding H; Goldberg MM; Raymer JH; Holmes J; Stanko J; Chaney SG
    Biol Trace Elem Res; 1999 Jan; 67(1):1-11. PubMed ID: 10065593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of platinum drug release and liposome stability in human plasma by CE-ICP-MS.
    Nguyen TT; Ostergaard J; Stürup S; Gammelgaard B
    Int J Pharm; 2013 Jun; 449(1-2):95-102. PubMed ID: 23583709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs.
    Corte-Rodríguez M; Espina M; Sierra LM; Blanco E; Ames T; Montes-Bayón M; Sanz-Medel A
    Biochem Pharmacol; 2015 Nov; 98(1):69-77. PubMed ID: 26352094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.
    Welters MJ; Maliepaard M; Jacobs-Bergmans AJ; Baan RA; Schellens JH; Ma J; van der Vijgh WJ; Braakhuis BJ; Fichtinger-Schepman AM
    Carcinogenesis; 1997 Sep; 18(9):1767-74. PubMed ID: 9328174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo detection of DNA adducts induced by cisplatin using capillary HPLC-ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster.
    García Sar D; Montes-Bayón M; Aguado Ortiz L; Blanco-González E; Sierra LM; Sanz-Medel A
    Anal Bioanal Chem; 2008 Jan; 390(1):37-44. PubMed ID: 17932658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elemental bioimaging in kidney by LA-ICP-MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies.
    Moreno-Gordaliza E; Giesen C; Lázaro A; Esteban-Fernández D; Humanes B; Cañas B; Panne U; Tejedor A; Jakubowski N; Gómez-Gómez MM
    Anal Chem; 2011 Oct; 83(20):7933-40. PubMed ID: 21913725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of a liposomal oxaliplatin drug formulation by capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry (CE-ICP-MS).
    Nguyen TT; Østergaard J; Stürup S; Gammelgaard B
    Anal Bioanal Chem; 2012 Feb; 402(6):2131-9. PubMed ID: 22245979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patients.
    Boffetta P; Fichtinger-Schepman AM; Weiderpass E; van Dijk-Knijnenburg HC; Stoter G; van Oosterom AT; Keizer HJ; Fosså SD; Kaldor J; Roy P
    Anticancer Drugs; 1998 Feb; 9(2):125-9. PubMed ID: 9510497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.
    Veal GJ; Dias C; Price L; Parry A; Errington J; Hale J; Pearson AD; Boddy AV; Newell DR; Tilby MJ
    Clin Cancer Res; 2001 Aug; 7(8):2205-12. PubMed ID: 11489793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated inductively coupled plasma mass spectrometry (ICP-MS) method for the quantification of total platinum content in plasma, plasma ultrafiltrate, urine and peritoneal fluid.
    Lemoine L; Thijssen E; Noben JP; Adriaensens P; Carleer R; Speeten KV
    J Pharm Biomed Anal; 2018 Apr; 152():39-46. PubMed ID: 29414017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of inductively coupled mass spectrometry for the determination of platinum in plasma.
    Allain P; Berre S; Mauras Y; Le Bouil A
    Biol Mass Spectrom; 1992 Mar; 21(3):141-3. PubMed ID: 1576172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of cisplatin-induced nephrotoxicity in vivo by selenomethionine: the effect on cisplatin-DNA adducts.
    García Sar D; Montes-Bayón M; Blanco González E; Sierra Zapico LM; Sanz-Medel A
    Chem Res Toxicol; 2011 Jun; 24(6):896-904. PubMed ID: 21491944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.